| Name | Liraglutide, MS Grade Peptide |
|---|---|
| Cat# | CPAP0353 |
| CAS# | 204656-20-2 |
| Description | Liraglutide is a long-acting analog of GLP-1 that has been developed for the treatment of type 2 diabetes. The palmitoyl group facilitates non-covalent binding to albumin which provides a circulating reservoir for liraglutide's GLP-1 activity. Binding to albumin hinders degradation by DPP IV and neutral endopeptidase, thereby prolonging the half-life of the circulating complex. |
| Chemical Formula | C172H265N43O51 |
| Molecular Weight | 3751.26 |
| Sequence | His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(gamma-Glu-Palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
Mailing Address:
